Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MRSKX | 25.85 | 0.30 | +1.17% |
| MFS Research International R6 | |||
| NWCCX | 43.01 | 0.27 | +0.63% |
| Nuveen Winslow Large-Cap Growth ESG C | |||
| UIISX | 18.10 | 0.08 | +0.44% |
| Victory Income Stock Institutional | |||
| HSLFX | 42.02 | 0.01 | +0.02% |
| Hartford Small Cap Growth F | |||
| BIPIX | 38.83 | -0.45 | -1.15% |
| ProFunds Biotechnology UltraSector Inv | |||
A.I.dvisor indicates that over the last year, GNMSF has been loosely correlated with GMAB. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if GNMSF jumps, then GMAB could also see price increases.
| Ticker / NAME | Correlation To GNMSF | 1D Price Change % | ||
|---|---|---|---|---|
| GNMSF | 100% | N/A | ||
| GMAB - GNMSF | 58% Loosely correlated | -1.11% | ||
| RIGL - GNMSF | 29% Poorly correlated | +3.84% | ||
| ARCT - GNMSF | 28% Poorly correlated | -7.49% | ||
| ATNM - GNMSF | 27% Poorly correlated | -12.35% | ||
| AGIO - GNMSF | 27% Poorly correlated | -0.53% | ||
More | ||||